nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—Muscle twitching—Liothyronine—hypothyroidism	0.0172	0.0268	CcSEcCtD
Pergolide—HTR2A—cerebellar cortex—hypothyroidism	0.0146	0.0677	CbGeAlD
Pergolide—DRD1—nerve—hypothyroidism	0.0138	0.0637	CbGeAlD
Pergolide—Cardiac failure congestive—Liothyronine—hypothyroidism	0.0135	0.021	CcSEcCtD
Pergolide—Acidosis—Liotrix—hypothyroidism	0.011	0.0172	CcSEcCtD
Pergolide—Angina pectoris—Liothyronine—hypothyroidism	0.0103	0.0161	CcSEcCtD
Pergolide—DRD4—heart—hypothyroidism	0.0101	0.047	CbGeAlD
Pergolide—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0093	0.0145	CcSEcCtD
Pergolide—Myocardial infarction—Liothyronine—hypothyroidism	0.00924	0.0144	CcSEcCtD
Pergolide—Intestinal obstruction—Liotrix—hypothyroidism	0.00893	0.0139	CcSEcCtD
Pergolide—Cyanosis—Liotrix—hypothyroidism	0.0086	0.0134	CcSEcCtD
Pergolide—DRD2—nerve—hypothyroidism	0.00813	0.0376	CbGeAlD
Pergolide—HTR2A—urine—hypothyroidism	0.00777	0.036	CbGeAlD
Pergolide—Abscess—Liotrix—hypothyroidism	0.0077	0.012	CcSEcCtD
Pergolide—Coma—Dextrothyroxine—hypothyroidism	0.00757	0.0118	CcSEcCtD
Pergolide—Coma—Levothyroxine—hypothyroidism	0.00757	0.0118	CcSEcCtD
Pergolide—Arrhythmia—Liothyronine—hypothyroidism	0.00756	0.0118	CcSEcCtD
Pergolide—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00722	0.0113	CcSEcCtD
Pergolide—Hyperkinesia—Levothyroxine—hypothyroidism	0.00722	0.0113	CcSEcCtD
Pergolide—CYP3A4—urine—hypothyroidism	0.00719	0.0333	CbGeAlD
Pergolide—CYP2D6—urine—hypothyroidism	0.00708	0.0328	CbGeAlD
Pergolide—Cellulitis—Liotrix—hypothyroidism	0.0067	0.0104	CcSEcCtD
Pergolide—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00663	0.0103	CcSEcCtD
Pergolide—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00663	0.0103	CcSEcCtD
Pergolide—Increased appetite—Dextrothyroxine—hypothyroidism	0.0064	0.00998	CcSEcCtD
Pergolide—Increased appetite—Levothyroxine—hypothyroidism	0.0064	0.00998	CcSEcCtD
Pergolide—Hypertension—Liothyronine—hypothyroidism	0.00636	0.00992	CcSEcCtD
Pergolide—DRD4—testis—hypothyroidism	0.00626	0.029	CbGeAlD
Pergolide—Muscle twitching—Liotrix—hypothyroidism	0.0062	0.00967	CcSEcCtD
Pergolide—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00616	0.0096	CcSEcCtD
Pergolide—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00616	0.0096	CcSEcCtD
Pergolide—Affect lability—Dextrothyroxine—hypothyroidism	0.00592	0.00923	CcSEcCtD
Pergolide—Affect lability—Levothyroxine—hypothyroidism	0.00592	0.00923	CcSEcCtD
Pergolide—Tachycardia—Liothyronine—hypothyroidism	0.00587	0.00916	CcSEcCtD
Pergolide—Cardiac arrest—Levothyroxine—hypothyroidism	0.00571	0.00891	CcSEcCtD
Pergolide—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00571	0.00891	CcSEcCtD
Pergolide—Mood swings—Dextrothyroxine—hypothyroidism	0.00569	0.00888	CcSEcCtD
Pergolide—Mood swings—Levothyroxine—hypothyroidism	0.00569	0.00888	CcSEcCtD
Pergolide—Hypotension—Liothyronine—hypothyroidism	0.00562	0.00877	CcSEcCtD
Pergolide—Dehydration—Dextrothyroxine—hypothyroidism	0.00559	0.00872	CcSEcCtD
Pergolide—Dehydration—Levothyroxine—hypothyroidism	0.00559	0.00872	CcSEcCtD
Pergolide—Coma—Liotrix—hypothyroidism	0.00556	0.00868	CcSEcCtD
Pergolide—HTR2A—nerve—hypothyroidism	0.00536	0.0248	CbGeAlD
Pergolide—Hyperkinesia—Liotrix—hypothyroidism	0.00531	0.00828	CcSEcCtD
Pergolide—Sepsis—Liotrix—hypothyroidism	0.00528	0.00824	CcSEcCtD
Pergolide—Dysphagia—Levothyroxine—hypothyroidism	0.00519	0.0081	CcSEcCtD
Pergolide—Dysphagia—Dextrothyroxine—hypothyroidism	0.00519	0.0081	CcSEcCtD
Pergolide—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00506	0.00789	CcSEcCtD
Pergolide—Angina pectoris—Levothyroxine—hypothyroidism	0.00506	0.00789	CcSEcCtD
Pergolide—Cardiac failure congestive—Liotrix—hypothyroidism	0.00487	0.0076	CcSEcCtD
Pergolide—Body temperature increased—Liothyronine—hypothyroidism	0.00475	0.00742	CcSEcCtD
Pergolide—Increased appetite—Liotrix—hypothyroidism	0.00471	0.00734	CcSEcCtD
Pergolide—Weight decreased—Dextrothyroxine—hypothyroidism	0.0047	0.00733	CcSEcCtD
Pergolide—Weight decreased—Levothyroxine—hypothyroidism	0.0047	0.00733	CcSEcCtD
Pergolide—DRD5—female gonad—hypothyroidism	0.00465	0.0215	CbGeAlD
Pergolide—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00457	0.00712	CcSEcCtD
Pergolide—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00457	0.00712	CcSEcCtD
Pergolide—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00454	0.00708	CcSEcCtD
Pergolide—Myocardial infarction—Levothyroxine—hypothyroidism	0.00454	0.00708	CcSEcCtD
Pergolide—Hypoglycaemia—Liotrix—hypothyroidism	0.00453	0.00706	CcSEcCtD
Pergolide—Cerebrovascular accident—Liotrix—hypothyroidism	0.00451	0.00704	CcSEcCtD
Pergolide—Sweating—Dextrothyroxine—hypothyroidism	0.00444	0.00692	CcSEcCtD
Pergolide—Sweating—Levothyroxine—hypothyroidism	0.00444	0.00692	CcSEcCtD
Pergolide—Affect lability—Liotrix—hypothyroidism	0.00435	0.00679	CcSEcCtD
Pergolide—Cardiac arrest—Liotrix—hypothyroidism	0.0042	0.00656	CcSEcCtD
Pergolide—Mood swings—Liotrix—hypothyroidism	0.00419	0.00653	CcSEcCtD
Pergolide—Dehydration—Liotrix—hypothyroidism	0.00411	0.00641	CcSEcCtD
Pergolide—Hypokalaemia—Liotrix—hypothyroidism	0.00402	0.00627	CcSEcCtD
Pergolide—HTR1B—cardiovascular system—hypothyroidism	0.0039	0.0181	CbGeAlD
Pergolide—HTR2B—adrenal cortex—hypothyroidism	0.00385	0.0178	CbGeAlD
Pergolide—Abdominal distension—Liotrix—hypothyroidism	0.00385	0.006	CcSEcCtD
Pergolide—Dysphagia—Liotrix—hypothyroidism	0.00382	0.00596	CcSEcCtD
Pergolide—HTR1D—cardiovascular system—hypothyroidism	0.00378	0.0175	CbGeAlD
Pergolide—HTR2B—heart—hypothyroidism	0.00373	0.0173	CbGeAlD
Pergolide—Angina pectoris—Liotrix—hypothyroidism	0.00372	0.0058	CcSEcCtD
Pergolide—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00371	0.00579	CcSEcCtD
Pergolide—Arrhythmia—Levothyroxine—hypothyroidism	0.00371	0.00579	CcSEcCtD
Pergolide—Bronchitis—Liotrix—hypothyroidism	0.00367	0.00573	CcSEcCtD
Pergolide—Alopecia—Levothyroxine—hypothyroidism	0.00367	0.00573	CcSEcCtD
Pergolide—Alopecia—Dextrothyroxine—hypothyroidism	0.00367	0.00573	CcSEcCtD
Pergolide—Tension—Levothyroxine—hypothyroidism	0.00355	0.00554	CcSEcCtD
Pergolide—Tension—Dextrothyroxine—hypothyroidism	0.00355	0.00554	CcSEcCtD
Pergolide—HTR2B—cardiovascular system—hypothyroidism	0.00352	0.0163	CbGeAlD
Pergolide—Nervousness—Levothyroxine—hypothyroidism	0.00352	0.00548	CcSEcCtD
Pergolide—Nervousness—Dextrothyroxine—hypothyroidism	0.00352	0.00548	CcSEcCtD
Pergolide—Weight decreased—Liotrix—hypothyroidism	0.00346	0.00539	CcSEcCtD
Pergolide—Tremor—Dextrothyroxine—hypothyroidism	0.00339	0.00529	CcSEcCtD
Pergolide—Tremor—Levothyroxine—hypothyroidism	0.00339	0.00529	CcSEcCtD
Pergolide—Acute coronary syndrome—Liotrix—hypothyroidism	0.00336	0.00524	CcSEcCtD
Pergolide—Renal failure—Liotrix—hypothyroidism	0.00335	0.00522	CcSEcCtD
Pergolide—Myocardial infarction—Liotrix—hypothyroidism	0.00334	0.00521	CcSEcCtD
Pergolide—Agitation—Dextrothyroxine—hypothyroidism	0.00333	0.00519	CcSEcCtD
Pergolide—Agitation—Levothyroxine—hypothyroidism	0.00333	0.00519	CcSEcCtD
Pergolide—Sweating—Liotrix—hypothyroidism	0.00327	0.00509	CcSEcCtD
Pergolide—Palpitations—Dextrothyroxine—hypothyroidism	0.0032	0.00499	CcSEcCtD
Pergolide—Palpitations—Levothyroxine—hypothyroidism	0.0032	0.00499	CcSEcCtD
Pergolide—HTR1A—cardiovascular system—hypothyroidism	0.00315	0.0146	CbGeAlD
Pergolide—Convulsion—Dextrothyroxine—hypothyroidism	0.00314	0.00489	CcSEcCtD
Pergolide—Convulsion—Levothyroxine—hypothyroidism	0.00314	0.00489	CcSEcCtD
Pergolide—Arthralgia—Dextrothyroxine—hypothyroidism	0.00308	0.00481	CcSEcCtD
Pergolide—Arthralgia—Levothyroxine—hypothyroidism	0.00308	0.00481	CcSEcCtD
Pergolide—ADRA1A—heart—hypothyroidism	0.00308	0.0143	CbGeAlD
Pergolide—Anxiety—Dextrothyroxine—hypothyroidism	0.00307	0.00479	CcSEcCtD
Pergolide—Anxiety—Levothyroxine—hypothyroidism	0.00307	0.00479	CcSEcCtD
Pergolide—ADRA2C—adrenal cortex—hypothyroidism	0.00303	0.014	CbGeAlD
Pergolide—Confusional state—Levothyroxine—hypothyroidism	0.00298	0.00465	CcSEcCtD
Pergolide—Confusional state—Dextrothyroxine—hypothyroidism	0.00298	0.00465	CcSEcCtD
Pergolide—KCNH2—heart—hypothyroidism	0.00297	0.0138	CbGeAlD
Pergolide—ADRA2C—heart—hypothyroidism	0.00293	0.0136	CbGeAlD
Pergolide—Shock—Dextrothyroxine—hypothyroidism	0.00291	0.00453	CcSEcCtD
Pergolide—Shock—Levothyroxine—hypothyroidism	0.00291	0.00453	CcSEcCtD
Pergolide—ADRA1A—cardiovascular system—hypothyroidism	0.0029	0.0134	CbGeAlD
Pergolide—Tachycardia—Dextrothyroxine—hypothyroidism	0.00288	0.0045	CcSEcCtD
Pergolide—Tachycardia—Levothyroxine—hypothyroidism	0.00288	0.0045	CcSEcCtD
Pergolide—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00286	0.00445	CcSEcCtD
Pergolide—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00286	0.00445	CcSEcCtD
Pergolide—KCNH2—cardiovascular system—hypothyroidism	0.00281	0.013	CbGeAlD
Pergolide—HTR2B—adrenal gland—hypothyroidism	0.00278	0.0129	CbGeAlD
Pergolide—HTR2B—blood—hypothyroidism	0.00278	0.0129	CbGeAlD
Pergolide—Arrhythmia—Liotrix—hypothyroidism	0.00273	0.00426	CcSEcCtD
Pergolide—Alopecia—Liotrix—hypothyroidism	0.0027	0.00421	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00269	0.0042	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00269	0.0042	CcSEcCtD
Pergolide—HTR2B—thyroid gland—hypothyroidism	0.00268	0.0124	CbGeAlD
Pergolide—Insomnia—Dextrothyroxine—hypothyroidism	0.00267	0.00417	CcSEcCtD
Pergolide—Insomnia—Levothyroxine—hypothyroidism	0.00267	0.00417	CcSEcCtD
Pergolide—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00263	0.00411	CcSEcCtD
Pergolide—Dyspnoea—Levothyroxine—hypothyroidism	0.00263	0.00411	CcSEcCtD
Pergolide—Flatulence—Liotrix—hypothyroidism	0.00262	0.00409	CcSEcCtD
Pergolide—Tension—Liotrix—hypothyroidism	0.00261	0.00407	CcSEcCtD
Pergolide—Dysgeusia—Liotrix—hypothyroidism	0.00261	0.00407	CcSEcCtD
Pergolide—Nervousness—Liotrix—hypothyroidism	0.00259	0.00403	CcSEcCtD
Pergolide—DRD2—pituitary gland—hypothyroidism	0.00252	0.0117	CbGeAlD
Pergolide—Tremor—Liotrix—hypothyroidism	0.00249	0.00389	CcSEcCtD
Pergolide—HTR1A—adrenal gland—hypothyroidism	0.00249	0.0115	CbGeAlD
Pergolide—KCNH2—pituitary gland—hypothyroidism	0.00248	0.0115	CbGeAlD
Pergolide—ADRA2C—pituitary gland—hypothyroidism	0.00245	0.0113	CbGeAlD
Pergolide—Agitation—Liotrix—hypothyroidism	0.00245	0.00382	CcSEcCtD
Pergolide—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00243	0.0038	CcSEcCtD
Pergolide—Feeling abnormal—Levothyroxine—hypothyroidism	0.00243	0.0038	CcSEcCtD
Pergolide—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00242	0.00377	CcSEcCtD
Pergolide—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00242	0.00377	CcSEcCtD
Pergolide—Syncope—Liotrix—hypothyroidism	0.00239	0.00372	CcSEcCtD
Pergolide—Palpitations—Liotrix—hypothyroidism	0.00235	0.00367	CcSEcCtD
Pergolide—ADRA2A—heart—hypothyroidism	0.00234	0.0108	CbGeAlD
Pergolide—Loss of consciousness—Liotrix—hypothyroidism	0.00234	0.00365	CcSEcCtD
Pergolide—Body temperature increased—Levothyroxine—hypothyroidism	0.00234	0.00364	CcSEcCtD
Pergolide—Abdominal pain—Levothyroxine—hypothyroidism	0.00234	0.00364	CcSEcCtD
Pergolide—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00234	0.00364	CcSEcCtD
Pergolide—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00234	0.00364	CcSEcCtD
Pergolide—Convulsion—Liotrix—hypothyroidism	0.00231	0.0036	CcSEcCtD
Pergolide—Hypertension—Liotrix—hypothyroidism	0.0023	0.00358	CcSEcCtD
Pergolide—ADRA1A—adrenal gland—hypothyroidism	0.0023	0.0106	CbGeAlD
Pergolide—ADRA1A—blood—hypothyroidism	0.0023	0.0106	CbGeAlD
Pergolide—Chest pain—Liotrix—hypothyroidism	0.00227	0.00354	CcSEcCtD
Pergolide—Arthralgia—Liotrix—hypothyroidism	0.00227	0.00354	CcSEcCtD
Pergolide—Anxiety—Liotrix—hypothyroidism	0.00226	0.00352	CcSEcCtD
Pergolide—KCNH2—adrenal gland—hypothyroidism	0.00222	0.0103	CbGeAlD
Pergolide—KCNH2—blood—hypothyroidism	0.00222	0.0103	CbGeAlD
Pergolide—Confusional state—Liotrix—hypothyroidism	0.00219	0.00342	CcSEcCtD
Pergolide—ADRA2C—adrenal gland—hypothyroidism	0.00219	0.0101	CbGeAlD
Pergolide—ADRA2C—blood—hypothyroidism	0.00219	0.0101	CbGeAlD
Pergolide—Oedema—Liotrix—hypothyroidism	0.00217	0.00339	CcSEcCtD
Pergolide—Infection—Liotrix—hypothyroidism	0.00216	0.00337	CcSEcCtD
Pergolide—Shock—Liotrix—hypothyroidism	0.00214	0.00333	CcSEcCtD
Pergolide—Tachycardia—Liotrix—hypothyroidism	0.00212	0.00331	CcSEcCtD
Pergolide—Asthenia—Levothyroxine—hypothyroidism	0.00212	0.00331	CcSEcCtD
Pergolide—Asthenia—Dextrothyroxine—hypothyroidism	0.00212	0.00331	CcSEcCtD
Pergolide—Hyperhidrosis—Liotrix—hypothyroidism	0.0021	0.00328	CcSEcCtD
Pergolide—Pruritus—Dextrothyroxine—hypothyroidism	0.00209	0.00326	CcSEcCtD
Pergolide—Pruritus—Levothyroxine—hypothyroidism	0.00209	0.00326	CcSEcCtD
Pergolide—Anorexia—Liotrix—hypothyroidism	0.00207	0.00323	CcSEcCtD
Pergolide—KCNH2—female gonad—hypothyroidism	0.00207	0.00958	CbGeAlD
Pergolide—ADRA2C—female gonad—hypothyroidism	0.00204	0.00945	CbGeAlD
Pergolide—Hypotension—Liotrix—hypothyroidism	0.00203	0.00317	CcSEcCtD
Pergolide—Diarrhoea—Levothyroxine—hypothyroidism	0.00202	0.00315	CcSEcCtD
Pergolide—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00202	0.00315	CcSEcCtD
Pergolide—ADRA2A—gonad—hypothyroidism	0.002	0.00928	CbGeAlD
Pergolide—HTR2A—heart—hypothyroidism	0.00199	0.00921	CbGeAlD
Pergolide—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00198	0.00309	CcSEcCtD
Pergolide—Insomnia—Liotrix—hypothyroidism	0.00197	0.00306	CcSEcCtD
Pergolide—ADRA2A—pituitary gland—hypothyroidism	0.00196	0.00905	CbGeAlD
Pergolide—Paraesthesia—Liotrix—hypothyroidism	0.00195	0.00304	CcSEcCtD
Pergolide—Dyspnoea—Liotrix—hypothyroidism	0.00194	0.00302	CcSEcCtD
Pergolide—HTR1A—cerebellum—hypothyroidism	0.0019	0.00881	CbGeAlD
Pergolide—Decreased appetite—Liotrix—hypothyroidism	0.00189	0.00295	CcSEcCtD
Pergolide—Vomiting—Levothyroxine—hypothyroidism	0.00188	0.00293	CcSEcCtD
Pergolide—Vomiting—Dextrothyroxine—hypothyroidism	0.00188	0.00293	CcSEcCtD
Pergolide—HTR2A—cardiovascular system—hypothyroidism	0.00188	0.00869	CbGeAlD
Pergolide—DRD2—testis—hypothyroidism	0.00186	0.00862	CbGeAlD
Pergolide—Rash—Dextrothyroxine—hypothyroidism	0.00186	0.0029	CcSEcCtD
Pergolide—Rash—Levothyroxine—hypothyroidism	0.00186	0.0029	CcSEcCtD
Pergolide—Dermatitis—Dextrothyroxine—hypothyroidism	0.00186	0.0029	CcSEcCtD
Pergolide—Dermatitis—Levothyroxine—hypothyroidism	0.00186	0.0029	CcSEcCtD
Pergolide—Constipation—Liotrix—hypothyroidism	0.00186	0.0029	CcSEcCtD
Pergolide—Headache—Levothyroxine—hypothyroidism	0.00185	0.00289	CcSEcCtD
Pergolide—Headache—Dextrothyroxine—hypothyroidism	0.00185	0.00289	CcSEcCtD
Pergolide—KCNH2—testis—hypothyroidism	0.00184	0.00849	CbGeAlD
Pergolide—ADRA2C—testis—hypothyroidism	0.00181	0.00838	CbGeAlD
Pergolide—ADRA1A—liver—hypothyroidism	0.0018	0.00832	CbGeAlD
Pergolide—Feeling abnormal—Liotrix—hypothyroidism	0.00179	0.00279	CcSEcCtD
Pergolide—Gastrointestinal pain—Liotrix—hypothyroidism	0.00178	0.00277	CcSEcCtD
Pergolide—ADRA1A—cerebellum—hypothyroidism	0.00175	0.00812	CbGeAlD
Pergolide—Nausea—Dextrothyroxine—hypothyroidism	0.00175	0.00274	CcSEcCtD
Pergolide—Nausea—Levothyroxine—hypothyroidism	0.00175	0.00274	CcSEcCtD
Pergolide—ADRA2A—adrenal gland—hypothyroidism	0.00175	0.00809	CbGeAlD
Pergolide—ADRA2A—blood—hypothyroidism	0.00175	0.00809	CbGeAlD
Pergolide—DRD2—cerebellum—hypothyroidism	0.00172	0.00796	CbGeAlD
Pergolide—Abdominal pain—Liotrix—hypothyroidism	0.00172	0.00268	CcSEcCtD
Pergolide—Body temperature increased—Liotrix—hypothyroidism	0.00172	0.00268	CcSEcCtD
Pergolide—ADRA2C—liver—hypothyroidism	0.00171	0.00792	CbGeAlD
Pergolide—HTR2A—gonad—hypothyroidism	0.0017	0.00789	CbGeAlD
Pergolide—KCNH2—cerebellum—hypothyroidism	0.00169	0.00785	CbGeAlD
Pergolide—ADRA2A—thyroid gland—hypothyroidism	0.00169	0.0078	CbGeAlD
Pergolide—ADRA2C—cerebellum—hypothyroidism	0.00167	0.00774	CbGeAlD
Pergolide—HTR2A—pituitary gland—hypothyroidism	0.00166	0.0077	CbGeAlD
Pergolide—ADRA2A—female gonad—hypothyroidism	0.00163	0.00754	CbGeAlD
Pergolide—Asthenia—Liotrix—hypothyroidism	0.00156	0.00243	CcSEcCtD
Pergolide—Pruritus—Liotrix—hypothyroidism	0.00154	0.0024	CcSEcCtD
Pergolide—Diarrhoea—Liotrix—hypothyroidism	0.00149	0.00232	CcSEcCtD
Pergolide—HTR2A—adrenal gland—hypothyroidism	0.00149	0.00688	CbGeAlD
Pergolide—HTR2A—blood—hypothyroidism	0.00149	0.00687	CbGeAlD
Pergolide—ADRA2A—testis—hypothyroidism	0.00144	0.00669	CbGeAlD
Pergolide—Dizziness—Liotrix—hypothyroidism	0.00144	0.00224	CcSEcCtD
Pergolide—Vomiting—Liotrix—hypothyroidism	0.00138	0.00215	CcSEcCtD
Pergolide—CYP3A4—blood—hypothyroidism	0.00137	0.00636	CbGeAlD
Pergolide—Rash—Liotrix—hypothyroidism	0.00137	0.00214	CcSEcCtD
Pergolide—Dermatitis—Liotrix—hypothyroidism	0.00137	0.00213	CcSEcCtD
Pergolide—Headache—Liotrix—hypothyroidism	0.00136	0.00212	CcSEcCtD
Pergolide—CYP2D6—blood—hypothyroidism	0.00135	0.00626	CbGeAlD
Pergolide—ADRA2A—cerebellum—hypothyroidism	0.00133	0.00618	CbGeAlD
Pergolide—Nausea—Liotrix—hypothyroidism	0.00129	0.00201	CcSEcCtD
Pergolide—CYP2D6—female gonad—hypothyroidism	0.00126	0.00584	CbGeAlD
Pergolide—HTR2A—testis—hypothyroidism	0.00123	0.00569	CbGeAlD
Pergolide—HTR2A—liver—hypothyroidism	0.00116	0.00538	CbGeAlD
Pergolide—HTR2A—cerebellum—hypothyroidism	0.00113	0.00525	CbGeAlD
Pergolide—CYP2D6—testis—hypothyroidism	0.00112	0.00518	CbGeAlD
Pergolide—CYP3A4—liver—hypothyroidism	0.00108	0.00498	CbGeAlD
Pergolide—CYP2D6—liver—hypothyroidism	0.00106	0.0049	CbGeAlD
Pergolide—CYP2D6—cerebellum—hypothyroidism	0.00103	0.00478	CbGeAlD
Pergolide—HTR2B—Signaling by GPCR—VAV3—hypothyroidism	0.000111	0.000774	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—AVP—hypothyroidism	0.000109	0.000764	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—AVP—hypothyroidism	0.000109	0.000764	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CLTC—hypothyroidism	0.000109	0.000762	CbGpPWpGaD
Pergolide—ADRA2C—GPCR ligand binding—POMC—hypothyroidism	0.000108	0.000758	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CLTC—hypothyroidism	0.000107	0.00075	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TSHB—hypothyroidism	0.000107	0.000748	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TSHR—hypothyroidism	0.000107	0.000748	CbGpPWpGaD
Pergolide—ADRA1B—GPCR ligand binding—POMC—hypothyroidism	0.000107	0.000746	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—AVP—hypothyroidism	0.000107	0.000746	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—VAV3—hypothyroidism	0.000104	0.00073	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—SH2B3—hypothyroidism	0.000103	0.000724	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—VAV3—hypothyroidism	0.000103	0.00072	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—VAV3—hypothyroidism	0.000103	0.00072	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—VAV3—hypothyroidism	0.000102	0.000716	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—SH2B3—hypothyroidism	0.000101	0.000709	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TSHB—hypothyroidism	0.000101	0.000705	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TSHR—hypothyroidism	0.000101	0.000705	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TRH—hypothyroidism	0.000101	0.000705	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—POMC—hypothyroidism	0.0001	0.000704	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—AVP—hypothyroidism	0.0001	0.000703	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—PRL—hypothyroidism	0.0001	0.000702	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—TSHB—hypothyroidism	0.0001	0.000702	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—SH2B3—hypothyroidism	9.97e-05	0.000698	CbGpPWpGaD
Pergolide—ADRA2B—Hemostasis—IGF1—hypothyroidism	9.97e-05	0.000698	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TSHR—hypothyroidism	9.94e-05	0.000696	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TSHB—hypothyroidism	9.94e-05	0.000696	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TSHB—hypothyroidism	9.94e-05	0.000696	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TSHR—hypothyroidism	9.94e-05	0.000696	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—AVP—hypothyroidism	9.91e-05	0.000694	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—AVP—hypothyroidism	9.91e-05	0.000694	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—VAV3—hypothyroidism	9.87e-05	0.000691	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CLTC—hypothyroidism	9.87e-05	0.000691	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—AVP—hypothyroidism	9.86e-05	0.00069	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	9.82e-05	0.000688	CbGpPWpGaD
Pergolide—DRD2—GPCR ligand binding—POMC—hypothyroidism	9.82e-05	0.000688	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TRH—hypothyroidism	9.72e-05	0.00068	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CLTC—hypothyroidism	9.71e-05	0.00068	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TRH—hypothyroidism	9.67e-05	0.000677	CbGpPWpGaD
Pergolide—HTR2A—GPCR ligand binding—POMC—hypothyroidism	9.66e-05	0.000677	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—VAV3—hypothyroidism	9.55e-05	0.000669	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—SH2B3—hypothyroidism	9.52e-05	0.000666	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—AVP—hypothyroidism	9.51e-05	0.000666	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	9.51e-05	0.000666	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	9.46e-05	0.000663	CbGpPWpGaD
Pergolide—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	9.46e-05	0.000663	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—VAV3—hypothyroidism	9.4e-05	0.000658	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TRH—hypothyroidism	9.4e-05	0.000658	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—IYD—hypothyroidism	9.37e-05	0.000656	CbGpPWpGaD
Pergolide—ADRA2C—Hemostasis—IGF1—hypothyroidism	9.31e-05	0.000652	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—VAV3—hypothyroidism	9.29e-05	0.00065	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—VAV3—hypothyroidism	9.27e-05	0.000649	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TRH—hypothyroidism	9.25e-05	0.000648	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—AVP—hypothyroidism	9.21e-05	0.000645	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—AVP—hypothyroidism	9.06e-05	0.000634	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—SH2B3—hypothyroidism	8.98e-05	0.000628	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TSHB—hypothyroidism	8.97e-05	0.000628	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TSHR—hypothyroidism	8.97e-05	0.000628	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—VAV3—hypothyroidism	8.97e-05	0.000628	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—AVP—hypothyroidism	8.95e-05	0.000627	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—AVP—hypothyroidism	8.93e-05	0.000625	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—PIK3C2A—hypothyroidism	8.93e-05	0.000625	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	8.92e-05	0.000625	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—SH2B3—hypothyroidism	8.86e-05	0.00062	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—SH2B3—hypothyroidism	8.86e-05	0.00062	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	8.83e-05	0.000619	CbGpPWpGaD
Pergolide—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	8.79e-05	0.000616	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—VAV3—hypothyroidism	8.68e-05	0.000608	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	8.67e-05	0.000607	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TSHB—hypothyroidism	8.66e-05	0.000606	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TSHR—hypothyroidism	8.66e-05	0.000606	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—AVP—hypothyroidism	8.64e-05	0.000605	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TSHR—hypothyroidism	8.61e-05	0.000603	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TSHB—hypothyroidism	8.61e-05	0.000603	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—AVP—hypothyroidism	8.59e-05	0.000602	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—VAV3—hypothyroidism	8.54e-05	0.000598	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	8.53e-05	0.000597	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TRH—hypothyroidism	8.53e-05	0.000597	CbGpPWpGaD
Pergolide—HTR1D—GPCR downstream signaling—POMC—hypothyroidism	8.48e-05	0.000593	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TRH—hypothyroidism	8.39e-05	0.000588	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TSHB—hypothyroidism	8.38e-05	0.000587	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TSHR—hypothyroidism	8.38e-05	0.000587	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—AVP—hypothyroidism	8.36e-05	0.000585	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—AVP—hypothyroidism	8.35e-05	0.000585	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	8.35e-05	0.000585	CbGpPWpGaD
Pergolide—HTR1B—GPCR downstream signaling—POMC—hypothyroidism	8.3e-05	0.000581	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TSHB—hypothyroidism	8.25e-05	0.000577	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TSHR—hypothyroidism	8.25e-05	0.000577	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—AVP—hypothyroidism	8.23e-05	0.000576	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	8.22e-05	0.000575	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TRH—hypothyroidism	8.22e-05	0.000575	CbGpPWpGaD
Pergolide—DRD4—GPCR downstream signaling—POMC—hypothyroidism	8.17e-05	0.000572	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—TSHB—hypothyroidism	8.14e-05	0.00057	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	8.05e-05	0.000563	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	8e-05	0.00056	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ATP5O—hypothyroidism	7.97e-05	0.000558	CbGpPWpGaD
Pergolide—CYP3A4—Biological oxidations—POMC—hypothyroidism	7.94e-05	0.000556	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—VAV3—hypothyroidism	7.87e-05	0.000551	CbGpPWpGaD
Pergolide—HTR2B—GPCR downstream signaling—POMC—hypothyroidism	7.8e-05	0.000546	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	7.76e-05	0.000543	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	7.75e-05	0.000542	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	7.72e-05	0.00054	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—POMC—hypothyroidism	7.7e-05	0.000539	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	7.68e-05	0.000538	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—PRL—hypothyroidism	7.68e-05	0.000537	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TRH—hypothyroidism	7.64e-05	0.000535	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TSHB—hypothyroidism	7.6e-05	0.000532	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TSHR—hypothyroidism	7.6e-05	0.000532	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	7.59e-05	0.000531	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—AVP—hypothyroidism	7.59e-05	0.000531	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—IGF1—hypothyroidism	7.56e-05	0.00053	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—POMC—hypothyroidism	7.54e-05	0.000528	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—PRL—hypothyroidism	7.52e-05	0.000526	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—SLC5A5—hypothyroidism	7.5e-05	0.000525	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—TPO—hypothyroidism	7.49e-05	0.000524	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TSHB—hypothyroidism	7.48e-05	0.000524	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TSHR—hypothyroidism	7.48e-05	0.000524	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	7.48e-05	0.000524	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SH2B3—hypothyroidism	7.47e-05	0.000523	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—AVP—hypothyroidism	7.46e-05	0.000523	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—POMC—hypothyroidism	7.42e-05	0.000519	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—PRL—hypothyroidism	7.4e-05	0.000518	CbGpPWpGaD
Pergolide—DRD1—GPCR downstream signaling—POMC—hypothyroidism	7.35e-05	0.000515	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SH2B3—hypothyroidism	7.35e-05	0.000515	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	7.32e-05	0.000513	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	7.32e-05	0.000513	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	7.31e-05	0.000512	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	7.25e-05	0.000508	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—POMC—hypothyroidism	7.25e-05	0.000508	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—POMC—hypothyroidism	7.25e-05	0.000508	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—VAV3—hypothyroidism	7.1e-05	0.000497	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—POMC—hypothyroidism	7.08e-05	0.000496	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—PRL—hypothyroidism	7.06e-05	0.000494	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	7.05e-05	0.000493	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—VAV3—hypothyroidism	6.95e-05	0.000487	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—VAV3—hypothyroidism	6.84e-05	0.000479	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AVP—hypothyroidism	6.84e-05	0.000479	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	6.81e-05	0.000477	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	6.81e-05	0.000477	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	6.79e-05	0.000475	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SH2B3—hypothyroidism	6.78e-05	0.000474	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AVP—hypothyroidism	6.7e-05	0.000469	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—POMC—hypothyroidism	6.68e-05	0.000467	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	6.67e-05	0.000467	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—PRL—hypothyroidism	6.66e-05	0.000466	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AVP—hypothyroidism	6.59e-05	0.000462	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—POMC—hypothyroidism	6.59e-05	0.000461	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—POMC—hypothyroidism	6.59e-05	0.000461	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—PRL—hypothyroidism	6.57e-05	0.00046	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—PRL—hypothyroidism	6.57e-05	0.00046	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	6.55e-05	0.000459	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—VAV3—hypothyroidism	6.53e-05	0.000457	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	6.53e-05	0.000457	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	6.32e-05	0.000443	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AVP—hypothyroidism	6.29e-05	0.000441	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	6.29e-05	0.00044	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—VAV3—hypothyroidism	6.16e-05	0.000431	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—POMC—hypothyroidism	6.12e-05	0.000428	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—SLC5A5—hypothyroidism	6.09e-05	0.000427	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—VAV3—hypothyroidism	6.08e-05	0.000426	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—VAV3—hypothyroidism	6.08e-05	0.000426	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	6.07e-05	0.000425	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—POMC—hypothyroidism	6.02e-05	0.000422	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	5.95e-05	0.000416	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—POMC—hypothyroidism	5.94e-05	0.000416	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AVP—hypothyroidism	5.93e-05	0.000416	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—PRL—hypothyroidism	5.93e-05	0.000415	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AVP—hypothyroidism	5.86e-05	0.00041	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AVP—hypothyroidism	5.86e-05	0.00041	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—POMC—hypothyroidism	5.74e-05	0.000402	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—PRL—hypothyroidism	5.73e-05	0.000401	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—POMC—hypothyroidism	5.71e-05	0.0004	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—IGF1—hypothyroidism	5.71e-05	0.0004	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—PRL—hypothyroidism	5.7e-05	0.000399	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—POMC—hypothyroidism	5.56e-05	0.000389	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—POMC—hypothyroidism	5.55e-05	0.000389	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—PRL—hypothyroidism	5.54e-05	0.000388	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	5.49e-05	0.000384	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—POMC—hypothyroidism	5.47e-05	0.000383	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	5.46e-05	0.000382	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—PRL—hypothyroidism	5.45e-05	0.000382	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	5.35e-05	0.000374	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—TSHB—hypothyroidism	5.3e-05	0.000371	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—VAV3—hypothyroidism	5.3e-05	0.000371	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AVP—hypothyroidism	5.29e-05	0.00037	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—VAV3—hypothyroidism	5.27e-05	0.000369	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—VAV3—hypothyroidism	5.13e-05	0.000359	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AVP—hypothyroidism	5.1e-05	0.000357	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AVP—hypothyroidism	5.08e-05	0.000355	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—VAV3—hypothyroidism	5.04e-05	0.000353	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—POMC—hypothyroidism	5.04e-05	0.000353	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PRL—hypothyroidism	5.03e-05	0.000352	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	4.97e-05	0.000348	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—POMC—hypothyroidism	4.96e-05	0.000347	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PRL—hypothyroidism	4.95e-05	0.000346	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AVP—hypothyroidism	4.94e-05	0.000346	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AVP—hypothyroidism	4.86e-05	0.00034	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	4.86e-05	0.00034	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PRL—hypothyroidism	4.84e-05	0.000339	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	4.73e-05	0.000331	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—VAV3—hypothyroidism	4.65e-05	0.000326	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—VAV3—hypothyroidism	4.58e-05	0.00032	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—POMC—hypothyroidism	4.55e-05	0.000318	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	4.51e-05	0.000316	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PRL—hypothyroidism	4.5e-05	0.000315	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AVP—hypothyroidism	4.48e-05	0.000314	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	4.48e-05	0.000314	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—POMC—hypothyroidism	4.45e-05	0.000312	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AVP—hypothyroidism	4.41e-05	0.000309	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—POMC—hypothyroidism	4.38e-05	0.000307	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IGF1—hypothyroidism	4.37e-05	0.000306	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AVP—hypothyroidism	4.32e-05	0.000302	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IGF1—hypothyroidism	4.28e-05	0.0003	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IGF1—hypothyroidism	4.21e-05	0.000295	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—POMC—hypothyroidism	4.18e-05	0.000293	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	4.16e-05	0.000292	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IGF1—hypothyroidism	4.02e-05	0.000282	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AVP—hypothyroidism	4.01e-05	0.000281	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—SLC5A5—hypothyroidism	3.97e-05	0.000278	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—POMC—hypothyroidism	3.94e-05	0.000276	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—POMC—hypothyroidism	3.92e-05	0.000275	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—POMC—hypothyroidism	3.89e-05	0.000272	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—POMC—hypothyroidism	3.89e-05	0.000272	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IGF1—hypothyroidism	3.79e-05	0.000266	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IGF1—hypothyroidism	3.74e-05	0.000262	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IGF1—hypothyroidism	3.74e-05	0.000262	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—POMC—hypothyroidism	3.51e-05	0.000246	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—TSHB—hypothyroidism	3.47e-05	0.000243	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—POMC—hypothyroidism	3.39e-05	0.000237	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	3.38e-05	0.000237	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—POMC—hypothyroidism	3.37e-05	0.000236	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—POMC—hypothyroidism	3.28e-05	0.00023	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IGF1—hypothyroidism	3.26e-05	0.000228	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IGF1—hypothyroidism	3.25e-05	0.000227	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—POMC—hypothyroidism	3.23e-05	0.000226	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—POMC—hypothyroidism	3.19e-05	0.000223	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IGF1—hypothyroidism	3.16e-05	0.000221	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IGF1—hypothyroidism	3.11e-05	0.000218	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	3.09e-05	0.000216	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—POMC—hypothyroidism	2.98e-05	0.000208	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—POMC—hypothyroidism	2.93e-05	0.000205	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—POMC—hypothyroidism	2.87e-05	0.000201	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IGF1—hypothyroidism	2.86e-05	0.000201	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IGF1—hypothyroidism	2.82e-05	0.000197	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	2.76e-05	0.000193	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—POMC—hypothyroidism	2.67e-05	0.000187	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.6e-05	0.000182	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	2.56e-05	0.00018	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—POMC—hypothyroidism	2.08e-05	0.000145	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—POMC—hypothyroidism	1.36e-05	9.51e-05	CbGpPWpGaD
